Average Co-Inventor Count = 3.57
ph-index = 23
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Warner-lambert Company (58 from 2,538 patents)
2. Millennium Pharmaceuticals Limited (7 from 850 patents)
3. Other (5 from 832,843 patents)
4. Genentech, Inc. (4 from 3,222 patents)
5. Valo Health, Inc. (2 from 29 patents)
6. Warner Lambert LLC (2 from 22 patents)
7. Forma Tm, LLC (2 from 10 patents)
8. Pfizer Corporation (1 from 4,455 patents)
77 patents:
1. 12336981 - Compounds and compositions for the inhibition of NAMPT
2. 11547701 - Compounds and compositions for the inhibition of NAMPT
3. 10772874 - Compounds and compositions for the inhibition of NAMPT
4. 10456382 - Compounds and compositions for the inhibition of NAMPT
5. 10272072 - Compounds and compositions for the inhibition of NAMPT
6. RE40667 - [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
7. 7250444 - Pyrrole-based HMG-CoA reductase inhibitors
8. 6951848 - Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
9. 6780883 - Amide inhibitors of microsomal triglyceride transfer protein
10. 6624196 - Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
11. 6548499 - Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
12. 6541521 - Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
13. 6534521 - 2-phenyl benzimidazole derivatives as MCP-1 antagonists
14. 6506751 - Thiazolidinone compounds useful as chemokine inhibitors
15. 6458806 - Aryl alkenamides derivatives as MCP-1 antagonists